The GI Motility Program offers a wide range of diagnostic and therapeutic services for patients
with motility disorders.
Procedures are performed with solid-state catheters, or in the case of the Bravo system,
ambulatory, 24- and 48-hour pH testing without the discomfort of a transnasal catheter.
New endoscopic treatments for GERD are successfully performed on an outpatient basis.
Advanced laparoscopic therapy completes the entire spectrum of the latest modalities.
Treatments for patients with pelvic diseases, such as female fecal incontinence, are a major focus.
|
|
|
 |
| |
Diagnosis |
|
| :: |
Ambulatory 24- and 48-hour pH testing and external recorder |
| :: |
Transit time measurement |
| :: |
Gastroduodenal manometry |
| :: |
Biliary manometry |
| :: |
Biofeedback |
Endoscopic Therapy for GERD |
| :: |
Stretta radiofrequency |
| :: |
Endocinch gastroplication |
| :: |
Endoscopic suture device (ESD) gastroplication |
| :: |
Pneumatic dilation for achalasia |
| :: |
Botulinum toxin (Botox) for achalasia |
Surgical Therapy |
| :: |
Laparoscopic fundoplication |
Pelvic Floor Center |
| :: |
Rectal manometry |
| :: |
Biofeedback |
| :: |
Rectal endoscopic ultrasound |
| :: |
Nerve blocks |
| :: |
Radiofrequency treatment for incontinence |
| :: |
Pudendal nerve latency testing |
|
| |
|